FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36538811000001103: Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112409801000001116 Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112409901000001110 Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Mexiletine true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Is a Mexiletine hydrochloride 200mg (Mexiletine 167mg) capsules true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has active ingredient Mexiletine true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has specific active ingredient Mexiletine hydrochloride true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Is a Namuscla true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) 100 capsule 10 x 10 capsules Has AMP True Namuscla 167mg capsules (Lupin Healthcare (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start